These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9266200)

  • 1. Pulmonary thrombo-embolism in nephrotic syndrome treated with tissue plasminogen activator.
    Reid CJ; Segal T
    Eur J Pediatr; 1997 Aug; 156(8):647-9. PubMed ID: 9266200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary thrombo-embolism in the nephrotic syndrome.
    Jones CL; Hébert D
    Pediatr Nephrol; 1991 Jan; 5(1):56-8. PubMed ID: 2025540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rt-PA thrombolysis in the treatment of massive pulmonary embolism].
    Van Hover P; Stockx L; Raat H; Vervloessem I; Vandenbosch G; Verhaeghe R; Baert AL
    J Belge Radiol; 1996 Nov; 79(5):208-10. PubMed ID: 8984107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of successful application of tissue plasminogen activator actilyse in complex intensive therapy for massive pulmonary artery embolism].
    Mierbekov EM; Artykbaev ZhT; Potseluev DD
    Anesteziol Reanimatol; 2004; (2):67-70. PubMed ID: 15206285
    [No Abstract]   [Full Text] [Related]  

  • 5. First trimester use of recombinant tissue plasminogen activator in pulmonary embolism.
    Huang WH; Kirz DS; Gallee RC; Gordey K
    Obstet Gynecol; 2000 Nov; 96(5 Pt 2):838. PubMed ID: 11094230
    [No Abstract]   [Full Text] [Related]  

  • 6. Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction.
    Meneveau N; Schiele F; Vuillemenot A; Valette B; Grollier G; Bernard Y; Bassand JP
    Eur Heart J; 1997 Jul; 18(7):1141-8. PubMed ID: 9243149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibrinolytic treatment of thrombus of the right atrium causing severe pulmonary embolism].
    Bardají A; Castander D; Guarinos J; Ridao C; Richart C
    Rev Esp Cardiol; 1998 Jan; 51(1):78-80. PubMed ID: 9522614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotic syndrome and pulmonary artery thrombosis.
    Ahmed K; Saeed E
    Am J Nephrol; 1995; 15(3):274-6. PubMed ID: 7618656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolysis in acute pulmonary embolism: to whom, how much and how?
    Jezek V
    Eur Heart J; 1997 Jul; 18(7):1045. PubMed ID: 9243132
    [No Abstract]   [Full Text] [Related]  

  • 10. High dose urokinase against massive pulmonary embolism in nephrotic syndrome.
    Chen G; Liu Y; Xie Y; Li J; Liu H; Sun L; Peng Y; Liu F
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):439-43. PubMed ID: 23386277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary microthrombi during left ventricular assist device implantation.
    Gregoric ID; Patel V; Radovancevic R; Bracey AW; Radovancevic B; Frazier OH
    Tex Heart Inst J; 2005; 32(2):228-31. PubMed ID: 16107123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Local fibrinolysis in massive pulmonary thromboembolism].
    Garro P; Ruiz J; Gener J; Muixart J
    Med Clin (Barc); 1996 Mar; 106(9):354. PubMed ID: 8667703
    [No Abstract]   [Full Text] [Related]  

  • 13. Massive pulmonary embolism: treatment with thrombus fragmentation and local fibrinolysis with recombinant human-tissue plasminogen activator.
    Stock KW; Jacob AL; Schnabel KJ; Bongartz G; Steinbrich W
    Cardiovasc Intervent Radiol; 1997; 20(5):364-8. PubMed ID: 9271647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mobile thrombus in the right atrium and pulmonary embolism: efficacy of thrombolytic treatment with alteplase].
    López-Haldón JE; Varela Aguilar JM; Martínez Martínez A; González de la Puente MA
    Med Clin (Barc); 1997 Feb; 108(5):198. PubMed ID: 9091727
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of a pulmonary embolism with low dose of tissue plasminogen activator after thoracic surgery.
    Shen L; Li Y; Hernandez-Arenas LA; Jiang G; Yang J
    Am J Emerg Med; 2016 Nov; 34(11):2259.e5-2259.e6. PubMed ID: 27266329
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary embolism thrombolysis: Do we need another agent?
    Goldhaber SZ
    Am Heart J; 1999 Jul; 138(1 Pt 1):1-2. PubMed ID: 10385751
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?
    Dalen JE; Alpert JS; Hirsh J
    Arch Intern Med; 1997 Dec 8-22; 157(22):2550-6. PubMed ID: 9531222
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thrombosis of superior longitudinal sinus and pulmonary embolism in nephrotic syndrome].
    Delmas MC; Cochat P; Ranchin B; Négrier C; Barre P; Bouvier R; David L
    Pediatrie; 1992; 47(1):31-5. PubMed ID: 1337773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary embolism associated with nephrotic syndrome in children: a preliminary report of 8 cases.
    Huang J; Yang J; Ding J
    Chin Med J (Engl); 2000 Mar; 113(3):251-3. PubMed ID: 11775257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator as an alternative to vena cava interruption in recurrent pulmonary thromboembolism.
    Hunker FD; Mason RE; Browne SD
    South Med J; 1990 Nov; 83(11):1305-6. PubMed ID: 2122525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.